A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
PHASE2
Head and neck cancer is the malignant tumor with the highest morbidity and ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy
NA
This study explores early breast cancer, focusing on triple-negative and hi...